Department of Surgery, Division of Urology, University of Utah, Salt Lake City, Utah, USA.
Curr Opin Urol. 2023 Jan 1;33(1):16-23. doi: 10.1097/MOU.0000000000001054. Epub 2022 Oct 13.
The sixth edition of the World Health Organization (WHO) laboratory manual for the examination and processing of human semen was recently published with specific step-by-step instructions for semen evaluation and sperm processing. Point-of-care (POC) testing for semen evaluation and microfluidics for sperm processing are rapidly evolving technologies that could impact how we evaluate and process sperm. Understanding the updated manual in the context of these novel technologies is important.
Proper standardization of semen evaluation and sperm processing will allow for consistent high-quality results among laboratories worldwide. POC testing could improve access to semen evaluations that generate referrals to male infertility specialists for further assessment. Microfluidics can select functional sperm with decreased DNA fragmentation in semen and testicular biopsy samples for assisted reproductive technology (ART). Clinical outcomes, such as pregnancy rates and live birth rates, have not been shown to be consistently improved with these technologies compared to conventional techniques, although high level evidence research in this area is limited.
POC testing and microfluidics have the potential to be combined with machine learning technologies to improve fertility care. If these technologies are appropriately optimized, they could change how we evaluate and process sperm, and potentially lead to improved ART outcomes.
世界卫生组织(WHO)最近发布了第六版人类精液检查和处理实验室手册,其中包含了精液评估和精子处理的具体分步说明。即时检测(POC)用于精液评估和用于精子处理的微流控技术是快速发展的技术,可能会影响我们评估和处理精子的方式。了解这些新技术背景下的更新手册非常重要。
适当的精液评估和精子处理标准化将允许全球实验室之间产生一致的高质量结果。POC 检测可以改善精液评估的获取,从而为男性不育症专家提供进一步评估的转诊。微流控技术可以选择具有较低 DNA 碎片的功能性精子,用于辅助生殖技术(ART)。与传统技术相比,这些技术并未显示出在临床结局(如妊娠率和活产率)方面始终得到改善,尽管该领域的高水平证据研究有限。
POC 检测和微流控技术有可能与机器学习技术相结合,以改善生育保健。如果这些技术得到适当优化,它们可能会改变我们评估和处理精子的方式,并有可能改善 ART 结局。